BackGenelink Overview

Genelink Receivables

Track Genelink's receivables ($150K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$146350.00
↓ 1.25% YoYΔ $-1852.00 vs prior year quarter

Peer trimmed avg / median

Loading

Genelink Receivables History

Loading

Genelink vs. peers: Receivables Comparison

Loading

Genelink Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Genelink (GNLKQ) FAQ

Genelink (GNLKQ) currently reports a receivables of $150K as of September 2013. That compares with $150K in the prior-year period — down 1.2% year over year. Use the charts on this page to explore Genelink's receivables history and peer comparisons.

Genelink's receivables decreased from $150K to $150K — a 1.2% year-over-year decrease (period ending September 2013). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genelink reported $150K in receivables as of September 2013. That compares with $150K in the prior-year period — down 1.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $150K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Genelink, and consider following GNLKQ for alerts when major investors trade the stock.

Genelink is classified in the Healthcare sector. On receivables, it currently shows $150K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GNLKQ with unrelated industries.